The p53 tumor suppressor protein can function as an activator and a repressor of gene transcription. Currently, the mechanism of transcriptional repression by p53 is poorly understood. To aid in clarifying this mechanism, we carried out studies designed to identify speci®c target genes that are down-regulated following p53 induction. Among the negative p53-response genes revealed by our screening protocols are those encoding stathmin (Op18), a tubulin-associated protein implicated in cell signaling pathways, and an FK506/rapamycinbinding protein, FKBP25. Stathmin and FKBP25 exhibit decreased expression in both human and murine immortalized and transformed cell lines following induction of wild-type p53 by several stimuli that result in DNA damage. Candidate p53-repressed genes such as these provide the necessary markers to delineate the mechanism and biological consequences of transcriptional repression mediated by p53.
The p53 tumor suppressor protein plays a critical role in mediating the response of a cell to numerous deleterious stresses, including genotoxic stress and hypoxia (Levine, 1997) . In normal cells, such stimuli result in increased p53 protein levels and activation of its function as a nuclear transcription factor. The biological outcome of p53 induction is either growth arrest or apoptosis, depending upon a number of factors such as cell type and level of p53 induced (Ko and Prives, 1996; White, 1996; Levine, 1997) . Attesting to the importance of normal p53 function in a cell, mutation or loss of p53 activity is one of the most frequent events in human cancer (Hollstein et al., 1994) .
Currently, the best-characterized activity of wildtype p53 is its transactivation function, or its ability to bind to DNA in a sequence-speci®c manner and to upregulate the expression of a set of target genes. A number of experimental approaches have been used to identify p53-activated genes, which include p21/waf1 (El-Deiry et al., 1993) , bax (Miyashita and Reed, 1995) , cyclin G (Okamoto and Beach, 1994) , GADD45 (Kastan et al., 1992) , and mdm2 (Barak et al., 1993; Wu et al., 1993) . The identi®cation of such transcriptional targets has facilitated eorts toward understanding the role and regulation of p53 in response to environmental stress. For example, mdm2 protein can physically interact with p53 protein, repressing the ability of p53 to act as a transcription factor and mediating its degradation (Momand et al., 1992; Haupt et al., 1997; Kubbutat et al., 1997) . Also, the cyclindependent kinase inhibitor p21/waf1 has a wellestablished role in the p53-induced G1 arrest of the cell cycle (El-Deiry et al., 1993) .
Several lines of evidence indicate that p53 also functions as a transcriptional repressor of cellular and viral genes whose promoters lack consensus p53 binding sites (Gottlieb and Oren, 1996; Ko and Prives, 1996; White, 1996) . It should be noted that early investigations describing p53's activity as a repressor were carried out in transient co-transfection assays, where strong transcriptional squelching associated with extremely high p53 protein levels likely contributed to the apparent inhibition of promoter activity by p53. In most cases, however, the corresponding endogenous genes are not repressed following p53 induction in a cell. More recently an endogenous gene that is repressed following physiological induction of p53 has been isolated and found to encode the microtubule-associated protein MAP4 (Murphy et al., 1996) . Other candidate p53-repressed genes have recently been identi®ed; these include DP-1 (Gopalkrishnan et al., 1998) , Wee1 (Leach et al., 1998) , DNA topoisomerase IIa (Wang et al., 1997) and presenilin I (Roperch et al., 1998) .
The molecular basis for transcriptional repression by p53 is not well understood. Moreover, the speci®c cellular responses and downstream signals associated with this activity remain to be de®ned. To begin to approach these issues, we carried out experiments aimed at isolating genes whose endogenous expression is down-regulated in response to p53 induction. Speci®cally, mRNA dierential display protocols were employed in a screen for cDNA clones exhibiting decreased expression following p53 induction in a cell line with a temperature-sensitive p53 protein. Two of the candidate p53-repressed genes revealed from these assays were stathmin/Op18 and an FK506-binding protein, FKBP25. Stathmin encodes a cytoplasmic phosphoprotein considered to be an important regulator of microtubule dynamics; FKBP25 encodes a 25 kDa member of a family of proteins with peptidylprolyl cis-trans-isomerase (PPIase) activity that bind to the immunosuppressants rapamycin and FK506. The present study was undertaken to examine the nature and kinetics of altered stathmin and FKBP25 gene expression following the activation of p53 function by dierent experimental treatments.
Dierential display was performed as described (Murphy et al., 1996) on the murine embryo fibroblast cell line Val5, which expresses a temperature-sensitive p53 protein (Wu et al., 1993) . At 398C the majority of p53 protein in these cells is in the mutant conformation, and is inactive. Temperature shift to 328C causes the p53 protein to assume wild-type (wt) conformation and activity, leading to a G1 growth arrest of the cells. Dierential display patterns from RNA isolated from Val5 cells grown at both temperatures was compared to temperature-shifted parental cells (10.1), which contain no p53. These analyses allowed for the identi®cation of two cDNA clones whose expression was down-regulated following temperature shift and wt p53 induction in Val5 cells, but not in 10.1 cells (data not shown). These cDNA species were cloned and sequenced, and found to be highly homologous to the human FKBP25 and stathmin genes (not shown).
cDNA clones containing the entire coding regions of murine FKBP25 (mFKBP25) and stathmin were isolated by RT ± PCR and used as probes to examine expression patterns following p53 induction in human and murine cells. As shown in Figure 1 , p53 induction in Val5 cells following temperature shift for 8 or 24 h results in an estimated 70 ± 90% decrease in levels of stathmin RNA (Figure 1a) , and a 40 ± 60% reduction in mFKBP25 RNA levels ( Figure 1b ). In contrast, these cells show no decrease in the steady state levels of GAPDH or b-actin transcripts under the same conditions ( Figure 1 ). We next examined the expression patterns of the stathmin and FKBP25 genes in human cells following physiologically relevant p53 induction. MT-2, a T-lymphoma cell line with wildtype p53, and CEM-SS, a T-cell line with mutant p53, were treated with the DNA damaging agent doxorubicin (adriamycin). At several time-points thereafter, RNA was isolated from the cells and examined by Northern blotting. By 30 h following doxorubicin treatment of the MT-2 cells, we observed an approximately 80% decrease in stathmin mRNA and an estimated 90% decrease in FKBP25 mRNA levels ( Figure 2a , lanes 1 ± 4). As a marker for p53 activation, the same Northern blot was hybridized with a probe for p21/waf1. Increased p21/waf1 expression was evident in the same samples that show a decreased expression of the FKBP25 and stathmin genes ( Figure  2a , lanes 1 ± 4). In contrast, doxorubicin-treated CEM-SS cells, with mutant p53, exhibited neither an induction of p21/waf1 nor a decrease in the expression of stathmin or FKBP25 (Figure 2a , lanes 5 ± 7). As an extension of these analyses, we analysed two additional human tumor cell lines with de®ned p53 status. As we had observed with the MT-2 cells, doxorubicin treatment of wt p53-containing MCF7 breast cancer cells led to a decrease in stathmin RNA levels ( Figure  2b , lanes 1 ± 3). These decreases in stathmin levels closely paralleled the post-translational stabilization of p53 protein in response to doxorubicin (Figure 2c ). In contrast, doxorubicin treatment did not lead to decreased stathmin levels in the p53-null lung adenocarcinoma cell line H1299 (Figure 2b , lanes 4 ± 6).
In a further eort to demonstrate the dependence of stathmin down-regulation on the presence of wt p53, we analysed stathmin expression in the human melanoma cell line CaCl, which contains wt p53. Additionally, we analysed a clonal derivative of this line that contains a stably-transfected human papilloma virus E6 gene (HPV16-E6) ; we have previously shown that the CaCl/E6 cell line is compromised for p53 expression and activity by the presence of the HPV16 E6 protein (Landers et al., 1997) . As shown in Figure 3 , doxorubicin treatment of CaCl cells leads to a 70% decrease in stathmin levels (Figure 3a, lanes 1 ±  2) . This decrease does not occur in the isogenic cell line stably-transfected with the HPV E6 gene (CaCl/E6, Figure 3a , lanes 2 ± 4). Western analysis of p53 protein levels in these two cell lines, before and after doxorubicin treatment, indicate that both p53 protein levels, and transactivation of the p53-target gene mdm2, are eectively abrogated by E6 expression (Figure 3b lanes 1 ± 4) . These data support the contention that wild-type, functionally active p53 is required for doxorubicin-induced down regulation of stathmin gene expression. Figure 1 Temperature shift results in decreased stathmin (a) and mFKBP25 (b) RNA levels in Val5 cells with temperature-sensitive p53. Total cellular RNA was isolated from the Val5 cells grown at 398C (mutant conformation of p53) and following temperatureshift to 328C (wild-type conformation of p53) for 8 and 24 h. Northern blots of the RNA samples (10 mg) were sequentially hybridized with the indicated radio-labeled cDNA probes. Data presented in all ®gures are representative of 2 ± 3 independent experiments. Quantitation of stathmin and FKBP25 mRNA expression in this and subsequent ®gures was carried out using NIH Image following normalization to GAPDH or b-actin. Fulllength coding region cDNAs for stathmin and mFKBP25 were generated by reverse-transcription polymerase chain reactions (RT ± PCR) and cloned into the vector pCR2.1 (Invitrogen). The following oligonucleotide primers were used to generate the cDNA probes: stathmin, 5'-GGAAGATGGCGGCGGCCG-3' (sense primer for human and murine sequence); 5'-CCTTA-GAGCTGAAGCACTGC-3' (antisense primer for human sequence) or 5'-CCGATCTGAAGTACTGGTTT-3' (antisense primer for murine sequence); FKBP25, 5'-ATGGCTTCTTCT-GATATCCAGGT-3' (sense); 5'-TTAGTCAGCTTCAGTCTC-GT-3' (antisense). The cDNA probes hybridize to stathmin transcripts having an approximate size of 1.4 kb, and to FKBP25 transcripts having an approximate size of 1 kb. The murine FKBP25 sequence has been submitted to the GenBank data base (accession number AF110812)
We next chose to ascertain whether p53 induction, independent of its downstream consequences (cell cycle arrest or apoptosis), is sucient to cause downregulation of stathmin levels. To address this issue, we used ultraviolet irradiation as a stimulus to activate p53 in CaCl and CaCl/E6 cells. UV doses of 10 J/m 2 and less have been shown to lead to stabilized and transcriptionally active p53 protein, but not to G1 arrest or apoptosis (Perry et al., 1993; Lu and Lane, 1993) , making UV irradiation a useful means to address this question. We also included in this study analyses of the immortalized ®broblast cell lines 10.1 and 12.1. These murine embryo ®broblast lines were established identically but dier in p53 status; 10.1 cells are null for p53, and 12.1 cells have wt p53 . Twenty-four hours following a UV dose of 2 J/m 2 , stathmin levels were markedly decreased in CaCl and 12.1 cells (wt p53), but not in 10.1 or CaCl/E6 cells (Figure 4a and b) . The level of the p53-induced gene mdm2 was fourfold increased in both CaCl and 12.1 cells following UV treatment, verifying that transcriptionally active p53 protein was induced (data not shown). Consistent with the ®ndings of others, this dose of UV radiation was not sucient to induce either growth arrest or apoptosis, however, as judged by¯ow cytometric analysis of treated cells (Figure 3c ). Therefore, p53 induction by low doses of UV leads to a down-regulation of stathmin expression that is independent of either G1 arrest or apoptosis. The combined data indicate that wt p53, induced by distinct agents (UV irradiation, temperature shift and doxorubicin treatment) in dierent cell types of human and mouse origin, leads to a decrease in the expression of the endogenous stathmin and FKBP25 genes. We have previously shown by nuclear run-on analyses that down-regulation of FKBP25 following p53 induction occurs via transcriptional repression of the FKBP25 gene promoter (Murphy et al., 1996) . These ®ndings argue that stathmin and FKBP25 are good candidates for endogenous p53-repressed genes, and point to the possibility that some of the biological consequences associated with p53 activation may be mediated through the repression of these genes.
The physiological consequences resulting from the down-regulation of FKBP25 and stathmin by p53 remain to be determined. However, the identi®cation of these candidate p53-repressed genes provides the necessary tools to dissect the mechanism of transcriptional repression by p53. Interestingly, we have noted that stimuli that normally induce wt p53, such as UV irradiation and doxorubicin treatment, consistently cause a mild up-regulation of stathmin in cells with mutated or deleted versions of p53 (see, for example, Figure 2a and b, lanes 6 and 7). While the mechanism of this up-regulation is unclear, it is tempting to speculate that loss of negative regulation by deletion/ mutation of p53 allows for the revelation of alternative, positive regulation of these promoters by agents of DNA damage. Alternatively, data from our laboratory indicate that p53 negatively regulates the Map4 and stathmin promoters in concert with another protein (Murphy et al., manuscript in preparation) ; this latter protein may itself be regulated positively by DNA damaging agents.
The identi®cation of stathmin/Op18 as a potential target of p53 transcriptional repression is of particular interest for several reasons. Sometimes referred to as oncoprotein 18 (Op18), prosolin or metablastin, stathmin is a conserved cellular phosphoprotein expressed at elevated levels in many cancers, including a subset of leukemias and breast carcinomas (Hanash et al., 1988; Brattsand et al., 1993; BieÁ che et al., 1998) . Stathmin physically interacts with tubulin dimers, and is believed to function as a critical regulator of microtubule dynamics (Belmont and Mitchison, 1996; Marklund et al., 1996; Jourdain et al., 1997) . Moreover, it has been proposed to function as a relay protein integrating diverse cell signaling pathways, with involvement in processes such as mitosis and differentiation (Sobel, 1991) . Another microtubule-associated protein with an important role in mediating microtubule dynamics is MAP4 (Olmsted, 1991; Hirokawa, 1994) . Notably, MAP4 and several isotypes of a and b tubulins also are down-regulated in response to p53-activation (Murphy et al., 1996; Zhang et al., 1998; Murphy et al., manuscript in preparation) . Conversely, a gene with homology to MAP4 has recently been shown to be up-regulated in response to p53 (Utrera et al., 1998) . Therefore, p53 activation in a cell appears to target microtubule proteins, and concomitant changes in microtubule dynamics following p53 induction may have roles in apoptosis or G2/ M arrest. Additional studies are needed to better understand the roles that p53-down-regulated genes such as the ones described in this study play in mediating the many functions of p53 in pathways of growth arrest and apoptosis. Figure 4 Northern analysis of stathmin and GAPDH in cell lines with wt p53 (CaCl, (a) and 12.1, (b)) and cells where p53 is compromised by deletion (10.1, (b)) or expression of HPV E6 (CaCl/E6, (a)). As indicated, cells were exposed to ultraviolet radiation of 2 J/m 2 , and RNA levels were assessed 24 h later. UV irradiation was supplied by a Spectroline lamp (Spectronics Corp.), and output was measured by a UV light meter (Fisher). (c) Flow cytometric analysis of cells treated in parallel to those in (a) and (b). Cells were ®xed and stained with propidium iodide as described (Murphy et al., 1996) , and analysed on a Becton Dickinson FacScan. G1, S (synthesis) and G2/M populations were calculated using the program CellQuest
